Clinical Trials List
2023-02-01 - 2027-06-30
Phase II
Recruiting4
ICD-10C23
Malignant neoplasm of gallbladder
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9156.0
Malignant neoplasm of gallbladder
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chang-Fang Chiu 無
- Chi-Ching Chen 無
- 王秀慈 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- I-CHEN WU Digestive System Department
- 高育青 Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
- 蘇勇曄 Division of Hematology & Oncology
- Hui-Ching Wang Division of Hematology & Oncology
- Tsung-Jang Yeh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林季宏 無
- 莊建淮 無
- 黃得瑞 無
- 李佳真 無
- Chia-Chi Lin 無
- 陳怡君 無
- 林宗哲 無
- JHE-CYUAN GUO 無
- 廖斌志 無
- Ying-Chun Shen 無
- Hsiang-Fong Kao 無
- 陳國興 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 姜乃榕 Division of Hematology & Oncology
- Shao-Jung Hsu Division of General Internal Medicine
- Ta-Chung Chao Division of Hematology & Oncology
- Jiun-I Lai Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
- Tien-Hua Chen Division of Hematology & Oncology
- Chun-Yu Liu Division of Hematology & Oncology
- Chien-An Liu Division of Radiology
- San-Chi Chen Division of Hematology & Oncology
- Yee Chao Division of Hematology & Oncology
- Chung-Pin Li Digestive System Department
- Mu-Hsin Chang Division of Hematology & Oncology
- Muh-Hwa Yang Division of Hematology & Oncology
- Hao-Wei Teng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
155 participants
